Thymoquinone Potentiates the Effect of Phenytoin against Electroshock-Induced Convulsions in Rats by Reducing the Hyperactivation of m-TOR Pathway and Neuroinflammation: Evidence from In Vivo, In Vitro and Computational Studies

Epilepsy is a chronic neurodegenerative disease characterized by multiple seizures, hereto 35% of patients remain poor responders. Phenytoin (PHT; 20 and 40 mg/kg) and thymoquinone (THQ; 40 and 80 mg/kg) were given alone and as a low dose combination for 14 days (p.o), prior to challenge with maxima...

Full description

Saved in:
Bibliographic Details
Main Authors: Faheem Hyder Pottoo (Author), Mohammed Salahuddin (Author), Firdos Alam Khan (Author), Fadhel Alomar (Author), Marwa Abdullah AL Dhamen (Author), Abrar Fouad Alhashim (Author), Hawra Hussain Alqattan (Author), Mohamed S. Gomaa (Author), Mohammad N. Alomary (Author)
Format: Book
Published: MDPI AG, 2021-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_1b8a59fae575450d8009aa7d9a72c8d3
042 |a dc 
100 1 0 |a Faheem Hyder Pottoo  |e author 
700 1 0 |a Mohammed Salahuddin  |e author 
700 1 0 |a Firdos Alam Khan  |e author 
700 1 0 |a Fadhel Alomar  |e author 
700 1 0 |a Marwa Abdullah AL Dhamen  |e author 
700 1 0 |a Abrar Fouad Alhashim  |e author 
700 1 0 |a Hawra Hussain Alqattan  |e author 
700 1 0 |a Mohamed S. Gomaa  |e author 
700 1 0 |a Mohammad N. Alomary  |e author 
245 0 0 |a Thymoquinone Potentiates the Effect of Phenytoin against Electroshock-Induced Convulsions in Rats by Reducing the Hyperactivation of m-TOR Pathway and Neuroinflammation: Evidence from In Vivo, In Vitro and Computational Studies 
260 |b MDPI AG,   |c 2021-11-01T00:00:00Z. 
500 |a 10.3390/ph14111132 
500 |a 1424-8247 
520 |a Epilepsy is a chronic neurodegenerative disease characterized by multiple seizures, hereto 35% of patients remain poor responders. Phenytoin (PHT; 20 and 40 mg/kg) and thymoquinone (THQ; 40 and 80 mg/kg) were given alone and as a low dose combination for 14 days (p.o), prior to challenge with maximal electroshock (MES; 180 mA, 220 V, 0.2 s). Apart from observing convulsions, hippocampal mTOR, IL-1β, IL-6 and TNF-α levels were measured. Hippocampal histomorphological analysis was also conducted. In vitro cell line studies and molecular docking studies were run in parallel. The results revealed the synergistic potential of the novel duo-drug combination regimen: PHT (20 mg/kg) and THQ (40 mg/kg) against MES-induced convulsions. MES amplified signaling through mTOR, and inflated the levels of proinflammatory markers (IL-1β, IL-6 and TNF-α), which was significantly averted (<i>p</i> < 0.001) with the said drug combination. The computational studies revealed that PHT and THQ cooperatively bind the active site on Akt (upstream target of m-TOR) and establish a good network of intermolecular interactions, which indicates the sequential inhibition of PI3K/Akt/m-TOR signaling with the combination. The combination also increased cell viability by 242.81% compared to 85.66% viability from the the toxic control. The results suggest that the PHT and THQ in combination possesses excellent anticonvulsant and neuroprotective effects. 
546 |a EN 
690 |a phenytoin 
690 |a thymoquinone 
690 |a PI3K/Akt/m-TOR signaling 
690 |a grand mal seizures 
690 |a neuronal inflammation 
690 |a convulsions 
690 |a Medicine 
690 |a R 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceuticals, Vol 14, Iss 11, p 1132 (2021) 
787 0 |n https://www.mdpi.com/1424-8247/14/11/1132 
787 0 |n https://doaj.org/toc/1424-8247 
856 4 1 |u https://doaj.org/article/1b8a59fae575450d8009aa7d9a72c8d3  |z Connect to this object online.